GleamWall
中文EN

NPHC NUTRA PHARMA CORP

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1119643 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-49.0%
TTM net income YoY-255.0%
TTM EPS YoY—
Revenue 3-yr CAGR-31.6%
Net income 3-yr CAGR—

Margins

Gross margin64.8%
Operating margin-1,017.8%
Net margin-3,370.6%
FCF margin—
EBITDA margin-1,011.4%

Returns

ROE—
ROA-731.5%
ROIC (approx.)—
Asset turnover0.22x

Leverage & solvency

Liabilities / assets3,505.0%
Debt / equity—
Current ratio0.02x
Interest coverage-68.24x

Cash quality & payout

Operating cash flow / net income0.19x
Accruals ratio-589.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$257,612$246,309
Cost of revenue$183,679$240,557
Gross profit$196,628$247,323
SG&A expense—$1.13M
Operating income-$1.46M-$878,421
Interest expense$22,870$21,237
Pretax income-$2.05M-$1.29M
Net income-$2.05M-$1.29M
EBITDA-$1.45M-$870,981
EPS (basic)0.000.00
EPS (diluted)0.000.00
Weighted avg. shares (diluted)7.78B7.67B
Balance sheet
Cash & equivalents$12,181$36,447
Short-term investments$17,600$17,600
Inventory$19,535$17,696
Current assets$459,583$374,837
PP&E, net$25,805$10,402
Total assets$622,601$599,495
Current liabilities$17.31M$15.27M
Short-term debt$9.62M$8.49M
Long-term debt$136,644$140,217
Total debt$9.76M$8.63M
Total liabilities$17.45M$15.41M
Shareholders' equity-$16.83M-$14.81M
Net debt$9.75M$8.59M
Shares outstanding7.10B7.10B
Cash flow statement
Operating cash flow-$1.16M-$423,959
Capital expenditure$26,052—
Free cash flow-$1.19M—
Investing cash flow-$51,052$41,300
Financing cash flow$1.19M$419,106
Depreciation & amortization$10,649$7,440
Stock-based compensation$26,667—

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.